<DOC>
	<DOC>NCT00634712</DOC>
	<brief_summary>A study to evaluate the effect of Atacand on patients with heart failure with preserved left ventricular function</brief_summary>
	<brief_title>Candesartan Cilexetil in Heart Failure Assessment of Reduction in Mortality and Morbidity (CHARM Preserved)</brief_title>
	<detailed_description />
	<mesh_term>Heart Failure</mesh_term>
	<mesh_term>Candesartan</mesh_term>
	<mesh_term>Candesartan cilexetil</mesh_term>
	<criteria>Male or female aged 18 or above Congestive Heart Failure with symptoms for more than 4 weeks before starting study Provision of informed consent Current low blood pressure with symptoms Liver disease considered significant by the study doctor Pregnant or lactating females</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2011</verification_date>
	<keyword>Congestive Heart Failure</keyword>
	<keyword>Atacand</keyword>
	<keyword>Candesartan</keyword>
</DOC>